USANA Health Sciences, Inc.
USNA
$14.96
$0.533.67%
NYSE
| 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -5.33% | 0.27% | 5.89% | 6.72% | 10.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.33% | 0.27% | 5.89% | 6.72% | 10.79% |
| Cost of Revenue | -3.68% | 13.33% | 28.16% | 24.35% | 24.42% |
| Gross Profit | -5.78% | -3.20% | 0.99% | 2.42% | 7.61% |
| SG&A Expenses | -1.87% | -2.49% | 0.59% | 12.57% | 9.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.28% | 1.06% | 5.98% | 15.07% | 12.36% |
| Operating Income | -45.32% | -11.47% | 4.84% | -92.15% | -6.29% |
| Income Before Tax | -200.44% | -7.61% | -59.95% | -90.36% | -6.86% |
| Income Tax Expenses | 8.10% | 14.19% | -2.91% | 5.69% | -14.31% |
| Earnings from Continuing Operations | -367.63% | -25.09% | -135.57% | -162.81% | 0.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 932.57% | 396.43% | -500.00% | -- | -- |
| Net Income | -321.46% | -20.07% | -139.85% | -161.49% | -7.45% |
| EBIT | -45.32% | -11.47% | 4.84% | -92.15% | -6.29% |
| EBITDA | -31.26% | -7.74% | 26.20% | -52.31% | 12.97% |
| EPS Basic | -321.80% | -17.24% | -141.61% | -164.12% | -4.66% |
| Normalized Basic EPS | 18.38% | 0.09% | -2.94% | -88.70% | -10.48% |
| EPS Diluted | -323.08% | -16.63% | -142.41% | -164.75% | -3.70% |
| Normalized Diluted EPS | 18.52% | 0.22% | -2.94% | -88.69% | -10.20% |
| Average Basic Shares Outstanding | -0.15% | -3.42% | -4.20% | -4.11% | -2.94% |
| Average Diluted Shares Outstanding | -0.27% | -3.53% | -4.20% | -4.14% | -3.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |